Bioequivalence and Bioavailability Forum 19:08 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Group Effect in Full Replicate Design [RSABE / ABEL]

posted by Helmut Homepage - Vienna, Austria, 2018-09-12 15:09  - Posting: # 19276
Views: 644

Hi Gm,

» We don't want to take any decisions on the basis of model terms.

Very good.

» Our thought is, we need to check group effect for both ABE and RSABE also.

Again: you have to include “group” as a factor in various ways (see below).

» If this correct, how the model is to be designed for RSABE?

As I wrote above

» » Honestly, I have no clue how to modify the models given in the progesterone-guidance.

Specifically the scaling-part…
For the ABE part (if swR <0.294) like the FDA’s Model II:

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,855 posts in 4,020 threads, 1,269 registered users;
online 34 (1 registered, 33 guests [including 25 identified bots]).

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed